Skip to search formSkip to main contentSkip to account menu

ambrisentan 5 MG Oral Tablet [Letairis]

Known as: AMBRISENTAN 5 mg ORAL TABLET, FILM COATED [Letairis], Letairis 5 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

13 relations
Allura Red AC DyeAluminum OxideCroscarmellose SodiumLactose Monohydrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
Ambrisentan [Volibris® (EU), Letairis® (USA)], an endothelin-1 receptor antagonist, is effective in treating WHO functional class… 
2016
2016
Ambrisentan in pulmonary arterial hypertension: a guide to its use in the EU
Ambrisentan [Volibris® (EU), Letairis® (USA)] is an effective and well-tolerated oral option for the treatment of pulmonary… 
2010
2010
Systémy řízení rizik léčiv a programy omezeného přístupu k léčivům v USA
Přehledný clanek se věnuje problematice systemů řizeni rizik leciv – akcnim planům minimalizovani rizika (RiskMAPs), strategii… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)